Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| BPC 157 | BPC-157 is a synthetic pentadecapeptide. Study shows that BPC-157 is beneficial for the treatment of ulcers in the stomach, intestinal damage such as fistulas and inflammatory disorders, bone and joint healing and growth rates, and organ damage. Uses: bpc-157, short for body protection compound-157, is a synthetic peptide derived from a small protein found in the stomach called bpc. it has attracted great interest in the field of drug discovery due to its promising therapeutic potential in various medical conditions. this peptide has been studied for its wound healing properties, tissue repair capabilities, anti-inflammatory effects, and pot. Group: Pharmaceutical. CAS No. 137525-51-0. Pack Sizes: 10 mg. Product ID: BAT-010081. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Jinflexin A | Jinflexin A is a remarkable and potent pharmacological natural compound, finding extensive application for studying various ailments such as rheumatoid arthritis, osteoarthritis and diverse inflammatory joint disorders. This multifaceted natural compound exerts its mechanism of action via the proficient inhibition of pro-inflammatory cytokine production. Group: Pharmaceutical. CAS No. 2055155-75-2. Pack Sizes: 1 mg. Product ID: NP5010. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Satraplatin | Satraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues-cisplatin, carboplatin, and oxaliplatin-must be given intravenously. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPC Biotech under the name SPERA (Satraplatin Expanded Rapid Access). The drug has also been used in the treatment of lung and ovarian cancers. The proposed mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing. Group: Pharmaceutical. CAS No. 129580-63-8. Pack Sizes: 50 mg. Product ID: B0084-056858. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
